193 related articles for article (PubMed ID: 24205095)
1. Association between the XRCC1 Arg399Gln polymorphism and risk of cancer: evidence from 297 case-control studies.
Yi L; Xiao-Feng H; Yun-Tao L; Hao L; Ye S; Song-Tao Q
PLoS One; 2013; 8(10):e78071. PubMed ID: 24205095
[TBL] [Abstract][Full Text] [Related]
2. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
[TBL] [Abstract][Full Text] [Related]
3. Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.
Feng YZ; Liu YL; He XF; Wei W; Shen XL; Xie DL
Tumour Biol; 2014 Nov; 35(11):10677-97. PubMed ID: 25064613
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the association between XRCC1 Arg399Gln polymorphism and glioma susceptibility.
Zhu W; Yao J; Li Y; Xu B
Tumour Biol; 2014 Apr; 35(4):3061-6. PubMed ID: 24258108
[TBL] [Abstract][Full Text] [Related]
5. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk.
Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S
Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482
[TBL] [Abstract][Full Text] [Related]
6. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
Li Y; Liu F; Tan SQ; Wang Y; Li SW
PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511
[TBL] [Abstract][Full Text] [Related]
7. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.
Wu D; Jiang H; Gu Q; Zhang D; Li Z
Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894
[TBL] [Abstract][Full Text] [Related]
8. XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.
Huang Y; Xie D; Tang N; Wang J; Zeng X; Zhao P; He L
Tumour Biol; 2014 Jan; 35(1):799-808. PubMed ID: 23990457
[TBL] [Abstract][Full Text] [Related]
9. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.
Qi Y; Cui L; Song Y; Li N
Mol Biol Rep; 2014 Feb; 41(2):879-87. PubMed ID: 24390232
[TBL] [Abstract][Full Text] [Related]
10. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.
Ma WQ; Han XQ; Wang X; Wang Y; Zhu Y; Liu NF
PLoS One; 2016; 11(11):e0166961. PubMed ID: 27870881
[TBL] [Abstract][Full Text] [Related]
11. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese.
Li Y; Huang Y; Cao YS; Zeng J; Tong WN; Xu SL; Zhuo AS
Tumour Biol; 2013 Dec; 34(6):3681-5. PubMed ID: 23884604
[TBL] [Abstract][Full Text] [Related]
13. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D
Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739
[TBL] [Abstract][Full Text] [Related]
14. Association of XRCC1 genetic polymorphism (Arg399Gln) with laryngeal cancer: a meta-analysis based on 4,031 subjects.
Chen W; Wang ZY; Xu FL; Wu KM; Zhang Y; Xu L; Wang QP
Tumour Biol; 2014 Feb; 35(2):1637-40. PubMed ID: 24194393
[TBL] [Abstract][Full Text] [Related]
15. Arg399Gln substitution in XRCC1 as a prognostic and predictive biomarker for prostate cancer: Evidence from 8662 subjects and a structural analysis.
Noureddini M; Mobasseri N; Karimian M; Behjati M; Nikzad H
J Gene Med; 2018 Oct; 20(10-11):e3053. PubMed ID: 30160806
[TBL] [Abstract][Full Text] [Related]
16. X-ray repair cross-complementing gene 1 Arg399Gln polymorphism and glioma risk among Asians: A meta-analysis based on 2 326 cases and 3 610 controls.
Zhang L; Qiu Z; Luo J; Shu W
Neural Regen Res; 2012 Oct; 7(29):2313-9. PubMed ID: 25538755
[TBL] [Abstract][Full Text] [Related]
17. XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
Liu B; Shen T
Tumour Biol; 2014 Jan; 35(1):507-12. PubMed ID: 24052436
[TBL] [Abstract][Full Text] [Related]
18. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
Xia S; Wu S; Wang M
Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875
[TBL] [Abstract][Full Text] [Related]
19. Association between XRCC1 and XRCC3 polymorphisms with lung cancer risk: a meta-analysis from case-control studies.
Huang G; Cai S; Wang W; Zhang Q; Liu A
PLoS One; 2013; 8(8):e68457. PubMed ID: 23990873
[TBL] [Abstract][Full Text] [Related]
20. Association of XRCC1 Arg399Gln Polymorphism with Colorectal Cancer Risk: A HuGE Meta Analysis of 35 Studies.
Forat-Yazdi M; Gholi-Nataj M; Neamatzadeh H; Nourbakhsh P; Shaker-Ardakani H
Asian Pac J Cancer Prev; 2015; 16(8):3285-91. PubMed ID: 25921133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
